IP Verse

Ortho-Condensed Pyridine And Pyrimidine Derivatives ( E.G. Purines ) As Protein Kinases Inhibitors

Patent No. EP2272517 (titled "Ortho-Condensed Pyridine And Pyrimidine Derivatives ( E.G. Purines ) As Protein Kinases Inhibitors") was filed by Astex Therapeutics on Oct 25, 2005. The application was issued on Sep 20, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJun 26, 2015POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2272517

ASTEX THERAPEUTICS
Application Number
EP10184485A
Filing Date
Oct 25, 2005
Status
Patent Maintained As Amended
Aug 18, 2017
Publication Date
Sep 20, 2017
External Links
Slate, Register , Google Patents